(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology >  Pharmaceutical Intermediates
 
 Pharmaceutical Intermediates Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
 1  2  Next »
The 2011 Top Ten World's Leading Life Science Intermediates Companies

A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, particularly Planning, Marketing, R&D, and Manufacturing....

 

$12500.00
       
Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

The report provides key data, information and analysis on the global glucose monitoring systems market. The report provides market landscape, competitive landscape and market trends information on the glucose monitoring systems market....

 

$3500.00
       
The 2011 Global Life Science Intermediates Market Dynamics and Trends

A concise market analysis, including:
  • Major U.S....

 

$2450.00
       
Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategic assessment of Bayer/Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 43 pages and 7 tables



 

$1900.00
       
Cambrex: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategic assessment of Cambrex, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 56 pages and 9 tables



 

$1900.00
       
Clariant: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 41 pages and 5 tables



 

$1900.00
       
DowPharma: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of DowPharma, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 53 pages and 5 tables



 

$1900.00
       
DSM: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of DSM, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 46 pages and 11 tables



 

$1900.00
       
Evonik: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of Evonik, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 45 pages and 9 tables



 

$1900.00
       
Lonza: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of Lonza, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 66 pages and 15 tables



 

$1900.00
       
Novasep: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of Novasep, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 37 pages and 1 table



 

$1900.00
       
Rhodia: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

A strategies assessment of Rhodia, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 63 pages and 7 tables



 

$1900.00
       
The 2011 Leading Life Science Intermediates Companies Strategic Directions

For each company, the report provides insightful strategic assessments, including:
  • Specific business, new product development and marketing strategies.
  • Strengths and weaknesses....

 

$1850.00
       
The 2011 Leading Life Science Intermediates Companies Marketing Tactics

For each company, the analysis presents:
  • Major promotional strategies.
  • Distribution approaches....

 

$1850.00
       
The 2011 Leading Life Science Intermediates Companies Collaborations

For each company, the report presents:
  • Major joint venture, distribution, OEM and licensing partners, both industrial and academic.
  • Terms of collaborative agreements and specific products involved....

 

$1850.00
       
The 2011 Leading Life Science Intermediates Companies Financial Analyses

Each company's analysis provides:
  • Sales and operating profit by division, product line, geographic region and country.
  • Five-year sales and profit performance....

 

$1850.00
       
The 2011 Leading Life Science Intermediates Companies Organizations and Management

For each company, the report provides:
  • History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies.
  • Recent acquisitions, divestitures and significant organizational changes....

 

$1850.00
       
The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs

For each company, the report provides:
  • Estimated R&D budget.
  • Research facilities and staff....

 

$1850.00
       
    1  2   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X